Dr. Rohit Bishnoi, MD
What this data tells you about Dr. Bishnoi
Dr. Rohit Bishnoi is a hematology in Riverview, FL, with 18 years in practice. Based on federal Medicare data, Dr. Bishnoi performed 70,881 Medicare services across 2,251 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bishnoi received a total of $1,958 from 31 pharmaceutical and/or device companies across 53 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bishnoi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (aprepitant) | 15,080 | $1 | $6 |
| Oxaliplatin chemotherapy injection | 14,060 | $0 | $18 |
| Iron infusion (Feraheme) | 11,730 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 7,700 | $43 | $157 |
| Paclitaxel chemotherapy injection | 4,803 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 4,560 | $19 | $64 |
| Dexamethasone injection (steroid) | 2,107 | $0 | $1 |
| Iron infusion (Monoferric) | 2,100 | $15 | $74 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,870 | $1 | $41 |
| Complete blood count (CBC) with differential | 891 | $8 | $29 |
| Injection, leucovorin calcium, per 50 mg | 891 | $3 | $14 |
| Epoetin alfa injection (Procrit) for anemia | 870 | $6 | $25 |
| Injection, fluorouracil, 500 mg | 667 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 327 | $91 | $421 |
| Injection, carboplatin, 50 mg | 318 | $2 | $39 |
| Injection of additional new drug or substance into vein | 300 | $11 | $66 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 250 | $20 | $103 |
| Office visit, established patient, complex (40-54 min) | 215 | $128 | $550 |
| Office visit, established patient (20-29 min) | 212 | $61 | $277 |
| Office visit, established patient (30-39 min) | 201 | $87 | $390 |
| Blood draw (venipuncture) | 175 | $8 | $9 |
| Anti-nausea injection (ondansetron/Zofran) | 164 | $0 | $3 |
| Drug injection, under skin or into muscle | 157 | $10 | $67 |
| Hospital follow-up visit, moderate complexity | 132 | $58 | $214 |
| Administration of additional new drug or substance into vein, 1 hour or less | 119 | $45 | $205 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 101 | $43 | $208 |
| Administration of chemotherapy into vein, each additional hour | 89 | $20 | $164 |
| Irrigation of implanted venous access drug delivery device | 78 | $17 | $83 |
| Injection, diphenhydramine hcl, up to 50 mg | 77 | $1 | $4 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 69 | $14 | $63 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 65 | $51 | $234 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 64 | $14 | $65 |
| New patient office visit (45-59 min) | 64 | $108 | $509 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 61 | $180 | $613 |
| Administration of additional new drug or substance into vein using push technique | 59 | $38 | $177 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 41 | $1 | $6 |
| Red blood count, automated test | 34 | $4 | $12 |
| New patient office visit, complex (60-74 min) | 33 | $147 | $673 |
| Unclassified drugs | 31 | $1 | $22 |
| Initial hospital admission, moderate complexity | 30 | $100 | $403 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 28 | $43 | $180 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 24 | $70 | $210 |
| New patient office visit (30-44 min) | 20 | $76 | $342 |
| Injection of drug or substance into vein | 14 | $27 | $121 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bishnoi is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bishnoi experienced with anti-nausea injection (aprepitant)?
Does Dr. Bishnoi receive payments from pharmaceutical companies?
How do Dr. Bishnoi's costs compare to other hematologys in Riverview?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology